Home LiteratureArticle Details
PMID: 3753996 Published · ppublish English Journal Article

Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

The Journal of experimental medicine ·Vol. 163 ·No. 3 ·1986-03-01 ·Pages 740-5

Nawroth PP, Stern DM

Abstract

Tumor necrosis factor/cachectin (TNF) is a mediator of the septic state, which involves diffuse abnormalities of coagulation throughout the vasculature. Since previous studies have shown that endothelial cells can play an active role in coagulation, we wished to determine whether TNF could modulate endothelial cell hemostatic properties. Incubation of purified recombinant TNF with cultured endothelial cells resulted in a time- and dose-dependent acquisition of tissue factor procoagulant activity. Concomitant with enhanced procoagulant activity, TNF also suppressed endothelial cell cofactor activity for the anticoagulant protein C pathway; both thrombin-mediated protein C activation and formation of functional activated protein C-protein S complex on the cell surface were considerably attenuated. Comparable concentrations of TNF (half-maximal affect at approximately 50 pM) and incubation times (half-maximal affect by 4 h after addition to cultures) were required for each of these changes in endothelial cell coagulant properties. This unidirectional shift in cell surface hemostatic properties favoring promotion of clot formation indicates that, in addition to leukocyte procoagulants, endothelium can potentially be instrumental in the pathogenesis of the thrombotic state associated with inflammatory and malignant disorders.

MeSH Terms
Animals Blood Coagulation/drug effects Cattle Cells, Cultured Endothelium/drug effects Factor X/physiology Glycoproteins/metabolism,pharmacology Hemostasis/drug effects Humans Protein C Thromboplastin/biosynthesis Tumor Necrosis Factor-alpha
Chemicals
Glycoproteins Protein C Tumor Necrosis Factor-alpha Factor X Thromboplastin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Nawroth P P
Stern D M
References (11)
11 references, click to expand
  1. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture.
    Thromb Res. 1985 Dec 1;40(5):677-91 PMID: 4089833
  2. A factor X-activating cysteine protease from malignant tissue.
    J Clin Invest. 1981 Jun;67(6):1665-71 PMID: 7016920
  3. Purification and characterization of bovine tissue factor.
    J Biol Chem. 1981 Aug 25;256(16):8324-31 PMID: 6790539
  4. Natural anticoagulant mechanisms.
    J Clin Invest. 1984 Jul;74(1):1-6 PMID: 6330171
  5. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
    J Exp Med. 1984 Aug 1;160(2):618-23 PMID: 6332168
  6. Self-regulation of procoagulant events on the endothelial cell surface.
    J Exp Med. 1985 Oct 1;162(4):1223-35 PMID: 3876401
  7. Protein C.
    Prog Hemost Thromb. 1984;7:25-54 PMID: 6099583
  8. An endothelial cell-dependent pathway of coagulation.
    Proc Natl Acad Sci U S A. 1985 Apr;82(8):2523-7 PMID: 3873069
  9. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  10. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
    Nature. 1985 Aug 8-14;316(6028):552-4 PMID: 2993897
  11. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1986-03-01
Pages
740-5
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188058
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]